Hemostats Industry To Observe Fastest Growth in Cardiovascular Surgery

The hemostats market generated a revenue of USD 3.01 billion in 2022, and it will reach USD 4.73 billion by 2030, propelling at 5.80% CAGR during the forecast period, as per a report by P&S Intelligence.

To learn more about this report: https://bit.ly/3MYngO7

This is credited to the development of new hemostasis products by numerous players, and the increasing oncologic, orthopedic, cardiac, gynecological, and reconstructive surgeries.

The mounting number of surgical procedures is also a main driving factor for this industry. Moreover, the need to achieve hemostasis during the surgical process and the availability of various management devices have increased significantly in recent years.

In 2022, orthopedic surgery dominated the hemostats market with over 34% share, and it will remain like this in the future. Due to the rising incidence of sports injuries, increasing road accidents, the mounting number of laparoscopic surgeries, the growing aging population, and escalating number of obesity and age-related diseases, such as osteoporosis and arthritis. 

The cardiovascular surgery category is projected to grow the fastest. This can be credited to the rising number of this kind of surgeries, the increasing problem of mental stress in people, and the growing incidence of cardiac disorders. The prevalence of cardiac diseases is increasing, as a result of sedentary lifestyles, and various other factors. 

North America accounted for the largest share, of approximately 32%, in 2022, and it will grow significantly in the future owing to the numerous research and development activities, increasing incidence of orthopedic and cardiac disease, and the presence of reputable healthcare businesses. 

Due to the increasing number of surgeries, numerous research and development activities, and the production of new hemostasis products, the hemostats industry will grow significantly in the future. 

Read More

Fibrin Glue Market is Projected to Grow During the Forecast Period

The fibrin glue market is projected to grow during the forecast period, at a CAGR of 10.9% owing to the surging number of burn cases and surgical procedures and increasing healthcare expenditure. In addition, the growing prevalence of chronic diseases, increasing geriatric population, and rising road accidents are supporting to market advance. Fibrin glue is a kind of tissue adhesive extracted from a human or animal source, which is primarily used for healing wounds, coagulating the blood, tackling hemorrhage, and sealing tissues.

On the basis of application, the fibrin glue market is broadly categorized into general, vascular, cardiac, and pulmonary surgery. Out of these, during the historical period (2013–2016), the cardiac surgery category dominated the market in terms of revenue, and it is predicted to maintain its dominance during the forecast period. This is attributed to the rising incidence of cardiovascular diseases across the globe, which is further leading to the increasing number of cardiovascular surgical procedures. Cardiac surgery includes surgical treatment for different heart diseases.

To Learn More About this Report@ http://bit.ly/38oy6Fs

As per the American Heart Association, in the U.S., nearly 85.6 million people are suffering from cardiovascular diseases. Further, the growing healthcare spending is being witnessed as the key factor driving the growth of the fibrin glue market. The healthcare expenditure includes the public and private spending on medical goods and services, public health and prevention programs, and administration. As per the Centers for Disease Control and Prevention (CDC), in the U.S., in 2014, the total health expenditure was $3.0 trillion and the per capita national health expenditure was $9,523.

According to a report of the U.K. Office for National Statistics (ONS), in 2014, the total healthcare expenditure stood at $297.8 billion. Owing to the changing lifestyle and poor availability of care, the prevalence of chronic diseases and lifestyle-associated diseases, such as respiratory diseases, cancer, and heart diseases, is rising, leading to the surging volume of surgeries, which, in turn, is resulting in the growth of the fibrin glue market. As per the CDC, in 2012, around 117.0 million people in the U.S. were diagnosed with one or more chronic health conditions.

Similarly, as per the International Agency for Research on Cancer, in 2008, approximately 12.7 million new patients were diagnosed with cancer, and the number is predicted to reach 21.4 million by 2030. Fibrin glue is consumed in many surgeries, such as wound closure, bronchial fistulas, corneal transplantation, laparoscopic liver biopsies, spine surgery, and pterygium surgery. As per the World Bank, in 2012, 30,537 surgeries were performed per 100,000 population in the U.S. Further in 2015, in Australia, the total number of surgical procedures performed was 28,907 per 100,000 population.

Hence, the growing number of surgical procedures and increasing healthcare expenditure are among the significant factors boosting the growth of the market.

Read More